Amryt Pharmaceuticals DAC
AMYTN/A
NASDAQHealthcare🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
AMYT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Oleogel-S10
Epidermolysis Bullosa
metreleptin
Partial Lipodystrophy
Lomitapide
Homozygous Familial Hypercholesterolaemia (HoFH)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oleogel-S10 | Phase 3 | Epidermolysis Bullosa | - | - |
metreleptin | Phase 3 | Partial Lipodystrophy | - | - |
Lomitapide | Phase 3 | Homozygous Familial Hypercholesterolaemia (HoFH) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply